Fig. 3
Complete reponse observed in a 79 year-old male with stage IV melanoma treated with IMM-101 followed by pembrolizumab (lung disease)
Fig. 3 | Journal of Translational Medicine
Complete reponse observed in a 79 year-old male with stage IV melanoma treated with IMM-101 followed by pembrolizumab (lung disease)